alexandrine derrien
Research Laboratory Manager at Henry M Jackson Foundation- Claim this Profile
Click to upgrade to our gold package
for the full feature experience.
Topline Score
Bio
Experience
-
Henry M Jackson Foundation
-
United States
-
Non-profit Organizations
-
1 - 100 Employee
-
Research Laboratory Manager
-
Jul 2017 - May 2018
Bethesda MD
-
-
-
BioMarker Strategies LLC
-
United States
-
Biotechnology Research
-
1 - 100 Employee
-
Research Scientist
-
Mar 2015 - Feb 2017
Rockville, Maryland
-
-
-
2020 gene
-
United States
-
Biotechnology
-
1 - 100 Employee
-
Project Manager
-
Sep 2010 - Aug 2014
Development of companion diagnostic for Kidney.: Identify biomarkers on mTor pathway that will be predictive of response to Rapamycin and the “rapalogs’ for patients with Kidney cancer. Develop multiplex IHC technology: research and adapt techniques of IHC to detect up to 10 markers from one tissue section.
-
-
scientist
-
Nov 2008 - Sep 2010
o Design experiences, write and execute protocols, analyze results for multiplex immunohistochemistry phase II development. o Optimize and trouble-shoot existing protocols (increase layer number, validate Antibodies, improve signal to noise ratio). o Write SOPs. o Demonstrated proof of concept of the new technology in development (specificity of hybridization of fluorescent Oligonucleotides (ODN) with complementary ODN immobilized on polycarbonate membrane. o Prepared conjugated… Show more o Design experiences, write and execute protocols, analyze results for multiplex immunohistochemistry phase II development. o Optimize and trouble-shoot existing protocols (increase layer number, validate Antibodies, improve signal to noise ratio). o Write SOPs. o Demonstrated proof of concept of the new technology in development (specificity of hybridization of fluorescent Oligonucleotides (ODN) with complementary ODN immobilized on polycarbonate membrane. o Prepared conjugated Antibodies (Biotinylated-; Streptavidin-, ODN-Antibodies). o Present results in the weekly lab meeting and summarized them every three months for the quarterly report to NIST.
-
-
-
Bioset
-
1 - 100 Employee
-
Research associate
-
Aug 2006 - Apr 2008
Drug development for medical device o Developed ELISA for synthetic peptide detection in Biological fluids (serum, plasma and urine). o Cultured cell lines (murine myoblast cell C2C12) and pluripotent stem cells (C3HT1/2). o Developed protocol for in vitro study of chondrogenic differentiation model. o Investigated biological activities and physical properties of mimetic peptides of synthesized by Bioset (primarily mimetic of TGF-beta superfamily peptides). o Performed… Show more Drug development for medical device o Developed ELISA for synthetic peptide detection in Biological fluids (serum, plasma and urine). o Cultured cell lines (murine myoblast cell C2C12) and pluripotent stem cells (C3HT1/2). o Developed protocol for in vitro study of chondrogenic differentiation model. o Investigated biological activities and physical properties of mimetic peptides of synthesized by Bioset (primarily mimetic of TGF-beta superfamily peptides). o Performed validation procedures. o Wrote SOPs. o Tested efficiency of peptides coating on different meshes. Show less
-
-
-
Children's Hospital Boston
-
United States
-
Truck Transportation
-
Research fellow
-
Jan 2003 - Dec 2005
Mechanical stress and cell adhesion o Cultured and transfected endothelial cells (HUVECs, MVEC etc…) using Amexa technology. o Characterized the response of Intergrin following mechanical stimulations. o Contributed to proposal renewal, wrote scientific papers, initiated scientific collaborations. o Presented in international meeting. o Supervised summer intern (Harvard REU program)
-
-
-
Justus Liebig Universität
-
Germany
-
Higher Education
-
Head molecular biology laboratory
-
Apr 2002 - Dec 2002
o Supervised the molecular biology laboratory. o Trained students and technician in molecular biology techniques. o Characterized Pex19 expression in mouse tissues.
-
-
-
-
Post-doctoral fellow
-
Feb 1998 - Feb 2002
Regulation of GPCR signaling pathway in response to activation of EGFr. Using HEK 293T and CHO cells, cultured in Petri Dishes: o Developed and optimized enzymatic and binding assays. o Expressed and purified recombinant proteins from transformed bacterial cultures. o Transfected eukaryotic cells. o Presented scientific discoveries in international meetings. o Supervised summer interns (assigned the projects and trained them in the techniques used).
-
-
Education
-
Université Claude Bernard Lyon 1
Ph.D., cell biology,